Tokyo, Jan. 30 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060507) titled 'Developing a scale to assess the psychosocial impact of comprehensive cancer genomic profiling testing' on Jan. 29.

Study Type: Observational

Primary Sponsor: Institute - National Cancer Center Institute for Cancer Control

Condition: Condition - Advanced cancer Classification by malignancy - Malignancy Genomic information - NO

Objective: Narrative objectives1 - The objective of this study is to evaluate the validity and reliability of the Multidimensional Impact of Cancer Risk Assessment for Comprehensive Genomic Profiling (MICRA-CGP), a scale developed to assess the psychosocial impact following the disclosure of comprehensive cancer genomic profiling (CGP) test results, in patients who have undergone CGP testing. Basic objectives2 - Others

Eligibility: Age-lower limit - 18 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - *Patients receiving care at the National Cancer Center Hospital(Chuo Hospital and East Hospital), Tochigi Cancer Center, Juntendo University Hospital, Yokohama Municipal Citizen's Hospital, Toyama Prefectural Central Hospital, Nagoya City University Hospital, University Hospital,Kyoto Prefectural University of Medicine, Keio University Hospital, Tokyo Metropolitan Komagome Hospital, or Kanagawa Cancer Center *Patients who have been diagnosed with solid tumors and have received an explanation of their diagnosis from healthcare professionals, and for whom the attending physician judges that a basic understanding of the disease has been obtained *Patients who are able to read and understand Japanese study documents and questionnaires and complete them independently *Patients aged 18 years or older Key exclusion criteria - *Individuals with difficulty reading or writing Japanese *Individuals deemed inappropriate for participation by the principal investigator Target Size - 150

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2025 Year 12 Month 10 Day Date of IRB - 2026 Year 12 Month 22 Day Anticipated trial start date - 2026 Year 01 Month 29 Day Last follow-up date - 2026 Year 06 Month 30 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069221

Disclaimer: Curated by HT Syndication.